Marvin Slepian

Marvin Slepian

Director/Miembro de la Junta en
Regenesis Biomedical, Inc.
.
70 años
Health Technology
Consumer Services
Electronic Technology

Perfil

Marvin J.
Slepian
is the founder of Focal, Inc. (founded in 1991), Hansen Medical, Inc. (founded in 2002), MC10, Inc. (founded in 2008), EndoTex Interventional Systems, Inc. (founded in 1995), Angiotrax, Inc. (founded in 1997), and SynCardia Systems LLC (founded in 2001).
Dr. Slepian currently holds the position of Director at Regenesis Biomedical, Inc., Director-Tissue Engineering & Professor at the University of Arizona (since 2011), Director at Nuvox Pharma LLC, and Chief Medical Officer & Director at Strike Photonics, Inc.Dr. Slepian previously held the position of Director at CardioGenesis Corp.
(from 2009 to 2011), Director at Organ Transport Systems, Inc., Director at ThromboVision, Inc., and Chief Medical Officer at Cardio Ventures Ltd. (from 2009 to 2011).
Dr. Slepian obtained his undergraduate degree from Princeton University in 1977 and his doctorate degree from The University of Cincinnati College of Medicine.

Cargos activos de Marvin Slepian

EmpresasCargoInicio
Corporate Officer/Principal 30/07/2009
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -

Antiguos cargos conocidos de Marvin Slepian.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/01/2011
Fundador -
Fundador -
Angiotrax, Inc.
Fundador -
HANSEN MEDICAL, INC. Fundador -
Ver el detalle de la experiencia de Marvin Slepian.

Formación de Marvin Slepian.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

92

Relaciones de 1er grado

16

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas16

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Angiotrax, Inc.

Commercial Services

Electronic Technology

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN